These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 21670419)

  • 41. Systemic Aldosterone, But Not Angiotensin II, Plays a Pivotal Role in the Pathogenesis of Renal Injury in Chronic Nitric Oxide-Deficient Male Rats.
    Suehiro T; Tsuruya K; Ikeda H; Toyonaga J; Yamada S; Noguchi H; Tokumoto M; Kitazono T
    Endocrinology; 2015 Jul; 156(7):2657-66. PubMed ID: 25872005
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of nitric oxide inhibition on kidney function in experimental renovascular hypertension.
    Dedeoglu IO; Springate JE
    Clin Exp Hypertens; 2001 Apr; 23(3):267-75. PubMed ID: 11339692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systemic arterial pressure response to two weeks of Tempol therapy in SHR: involvement of NO, the RAS, and oxidative stress.
    Yanes L; Romero D; Iliescu R; Cucchiarelli VE; Fortepiani LA; Santacruz F; Bell W; Zhang H; Reckelhoff JF
    Am J Physiol Regul Integr Comp Physiol; 2005 Apr; 288(4):R903-8. PubMed ID: 15604302
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vimentin and heat shock protein expression are induced in the kidney by angiotensin and by nitric oxide inhibition.
    Bravo J; Quiroz Y; Pons H; Parra G; Herrera-Acosta J; Johnson RJ; Rodríguez-Iturbe B
    Kidney Int Suppl; 2003 Oct; (86):S46-51. PubMed ID: 12969127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model.
    Soares-da-Silva P; Pestana M; Vieira-Coelho MA; Fernandes MH; Albino-Teixeira A
    Br J Pharmacol; 1995 Apr; 114(7):1403-13. PubMed ID: 7541690
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adenosine A₁-receptor deficiency diminishes afferent arteriolar and blood pressure responses during nitric oxide inhibition and angiotensin II treatment.
    Gao X; Patzak A; Sendeski M; Scheffer PG; Teerlink T; Sällström J; Fredholm BB; Persson AE; Carlström M
    Am J Physiol Regul Integr Comp Physiol; 2011 Dec; 301(6):R1669-81. PubMed ID: 21975649
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats.
    Koshikawa S; Nishikimi T; Inaba C; Akimoto K; Matsuoka H
    J Hypertens; 2008 Sep; 26(9):1837-48. PubMed ID: 18698220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early co-expression of cyclooxygenase-2 and renin in the rat kidney cortex contributes to the development of N(G)-nitro-L-arginine methyl ester induced hypertension.
    Guzmán-Hernández EA; Villalobos-Molina R; Sánchez-Mendoza MA; Del Valle-Mondragón L; Pastelín-Hernández G; Ibarra-Barajas M
    Can J Physiol Pharmacol; 2015 Apr; 93(4):299-308. PubMed ID: 25761067
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NADPH oxidase-induced oxidative stress in the eyes of hypertensive rats.
    Santana-Garrido Á; Reyes-Goya C; Fernández-Bobadilla C; Blanca AJ; André H; Mate A; Vázquez CM
    Mol Vis; 2021; 27():161-178. PubMed ID: 33907371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. N(G)-nitro-L-arginine methyl ester-induced hypertension and natriuretic peptide gene expression: inhibition by angiotensin II type 1 receptor antagonism.
    Suo M; Kalliovalkama J; Pörsti I; Jolma P; Tolvanen JP; Vuolteenaho O; Ruskoaho H
    J Cardiovasc Pharmacol; 2002 Sep; 40(3):478-86. PubMed ID: 12198334
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of endogenous nitric oxide in angiotensin II-induced activation of vascular mitogen-activated protein kinases.
    Zhang GX; Nagai Y; Nakagawa T; Miyanaka H; Fujisawa Y; Nishiyama A; Izuishi K; Ohmori K; Kimura S
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2403-8. PubMed ID: 17616751
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of nitric oxide synthase inhibition on angiotensin receptors and metabolism in the pregnant hypertensive rat.
    Yang Y; Macdonald GJ; Duggan KA
    Clin Sci (Lond); 2001 Mar; 100(3):319-26. PubMed ID: 11222119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Control of arterial pressure by angiotensin II and nitric oxide at the onset of diabetes.
    Brands MW; Cloud LJ
    Am J Hypertens; 2003 Jul; 16(7):600-3. PubMed ID: 12850396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hydrogen sulfide defends against the cardiovascular risk of Nw-nitro-L-argininemethyl ester-induced hypertension in rats via the nitric oxide/endothelial nitric oxide synthase pathway.
    Ji W; Liu S; Dai J; Yang T; Jiang X; Duan X; Wu Y
    Chin Med J (Engl); 2014; 127(21):3751-7. PubMed ID: 25382331
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term nitric oxide blockade in the pregnant rat: effects on blood pressure and plasma levels of endothelin-1.
    Edwards DL; Arora CP; Bui DT; Castro LC
    Am J Obstet Gynecol; 1996 Aug; 175(2):484-8. PubMed ID: 8765273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nitric oxide regulation of TP receptor-mediated pulmonary vasoconstriction in the anesthetized, open-chest rat.
    Valentin JP; Bessac AM; Maffre M; John GW
    Eur J Pharmacol; 1996 Dec; 317(2-3):335-42. PubMed ID: 8997619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism.
    Gohlke P; Pees C; Unger T
    Hypertension; 1998 Jan; 31(1 Pt 2):349-55. PubMed ID: 9453327
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Salt-sensitive hypertension resulting from nitric oxide synthase inhibition is associated with loss of regulation of angiotensin II in the rat.
    Hodge G; Ye VZ; Duggan KA
    Exp Physiol; 2002 Jan; 87(1):1-8. PubMed ID: 11805851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tetrahydrocurcumin alleviates hypertension, aortic stiffening and oxidative stress in rats with nitric oxide deficiency.
    Nakmareong S; Kukongviriyapan U; Pakdeechote P; Kukongviriyapan V; Kongyingyoes B; Donpunha W; Prachaney P; Phisalaphong C
    Hypertens Res; 2012 Apr; 35(4):418-25. PubMed ID: 22072109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Limonin ameliorates cardiovascular dysfunction and remodeling in hypertensive rats.
    Iampanichakul M; Potue P; Rattanakanokchai S; Maneesai P; Khamseekaew J; Settheetham-Ishida W; Pakdeechote P
    Life Sci; 2023 Aug; 327():121834. PubMed ID: 37290669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.